PMID: 6112177Jan 1, 1981Paper

Responses of neonatal rat islets to streptozotocin: limited B-cell regeneration and hyperglycemia

Diabetes
S Bonner-WeirG C Weir

Abstract

Streptozotocin (SZ) was given to 2-day-old neonatal rats, and, during their subsequent development, the interrelationships between plasma glucose, plasma insulin, pancreatic islet morphology, and hormone content were examined. At 4 days of age, a peak of hyperglycemia was observed (SZ, 349 plus or minus 8 mg/dl versus control (C), 127 plus or minus 2) that was associated with a marked reduction of B-cell numbers (SZ, 26.5 plus or minus 2.6% B-cell per islet versus C, 72.8 plus or minus 0.8%). By 10 days of age the SZ animals became normoglycemia with partial recovery of the B-cell number (SZ, 39.6 plus or minus 2.1% versus, C, 64.0 plus or minus 2.6%). By six weeks hyperglycemia returned (SZ, 345 plus or minus 5.2 mg/dl versus C, 171 plus or minus 6.2) with B-cell number of the SZ being 72% of the C (SZ, 48.8 plus or minus 2.4% versus C, 67.5 plus or minus 1.5%). This hyperglycemia and reduced B-cell number persisted to at least 13 wk age. Despite a marked reduction of pancreatic insulin content observed during development, there was little effect upon glucagon or somatostatin content. At 6 wk of age, the plasma insulin concentration was only 30% of C, which suggests as insulin secretory defect beyond that which could be accoun...Continue Reading

Citations

Oct 1, 1993·Journal of Bioenergetics and Biomembranes·R S Kaplan, J A Mayor
Sep 18, 1991·Molecular and Cellular Biochemistry·R S KaplanS W Schaffer
Feb 1, 1988·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·B AmoryC Remacle
Jul 24, 2010·Current Atherosclerosis Reports·Patrick MurrayVasudevan A Raghavan
Jul 1, 1987·Metabolism: Clinical and Experimental·M IwaseM Fujishima
Oct 1, 1983·Physiology & Behavior·T J Bartness, N E Rowland
Nov 6, 1982·Lancet·T HelgasonJ M Stowers
May 15, 2002·Diabetes Research and Clinical Practice·Vesselina Ogneva, Yordanka Martinova
Dec 25, 2002·Journal of Ethnopharmacology·Shrabana ChakrabartiBiswapati Mukherjee
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B ThorensS Bonner-Weir
Mar 20, 2009·Natural Product Research·Ismet Ara JahanM Iqbal Choudhary
Oct 9, 2007·Diabetes, Obesity & Metabolism·J MovassatB Portha
Oct 18, 2008·Diabetes, Obesity & Metabolism·C Kargar, A Ktorza
Sep 7, 2012·Diabetes, Obesity & Metabolism·D DadonB Glaser
Oct 23, 2003·Annual Review of Cell and Developmental Biology·L Charles Murtaugh, Douglas A Melton
Jun 1, 1983·The Journal of Clinical Investigation·S Bonner-WeirG C Weir
Sep 1, 1990·The Journal of Clinical Investigation·P MedaL Orci
Oct 21, 2009·Diabetology & Metabolic Syndrome·Ana Ci KissDébora C Damasceno
Apr 27, 2010·Diabetology & Metabolic Syndrome·Felipe H SaitoMarilza Vc Rudge
Jun 10, 2010·Diabetology & Metabolic Syndrome·Isabela L IessiDébora C Damasceno
Jan 14, 2012·Endocrine Reviews·Jia-Ming Xu, Guo-Ping Shi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.